IP Library › Granted Patent US 10,399,982
Granted Patent B2
US 10,399,982 · App. 15/968,941 · Granted Sep 3, 2019

Substituted xanthines and methods of use thereof

Inventors: Bertrand L. Chenard (Waterford, CT); Randall J. Gallaschun (Lebanon, CT)
Assignee: Hydra Biosciences, Inc.
C07D473/04C07D473/06C07D487/04C07D487/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,399,982
App. No.
15/968,941
Granted
Sep 3, 2019
Kind
B2
Abstract

Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

Claims (5)

1. A compound that is

2. A compound that is

3. A compound that is

4. A compound that is

5. A compound that is

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2025
From: HYDRA BIOSCIENCES, LLC
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 072599/0843 →
CERTIFICATE OF MERGER Recorded Nov 4, 2019
From: HYDRA BIOSCIENCES, INC.
To: HYDRA BIOSCIENCES, LLC
Reel/Frame 050917/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: CHENARD, BERTRAND L.; GALLASCHUN, RANDALL J.
To: HYDRA BIOSCIENCES, INC.
Reel/Frame 047269/0416 →
Continuity (5)
Continuation 15622838 · Jun 14, 2017
Continuation 15137327 · Apr 25, 2016
Continuation 14210781 · Mar 14, 2014
Provisional Application 61789724 · Mar 15, 2013
Related Publication 20180244674A1 · Aug 30, 2018